Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of NoL Index and ANI After Nociceptive Stimulation at Different Infusion Rates of Remifentanil Infusion

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02602379
Recruitment Status : Completed
First Posted : November 11, 2015
Last Update Posted : November 18, 2016
Sponsor:
Collaborator:
Medasense Biometrics Ltd
Information provided by (Responsible Party):
Philippe Richebé, Maisonneuve-Rosemont Hospital

Brief Summary:

Contrary to "immobility" and, to a lesser extent, to the "hypnosis/unconsciousness" component of general anaesthesia, the monitoring of "analgesia" remains largely elusive, evaluated mainly through poorly sensitive and potentially undesirable changes in patients' vital signs. This has led the industry to pursue the development of various devices and indices based on other physiological parameters such as heart rate variability (HRV), electroencephalogram (EEG), skin conductance, to name only a few. To the best of the knowledge, none of these parameters on its own has shown sufficient capacity in detecting different degrees of pain/analgesia balance to gain wide clinical use.

The purpose of this prospective observational study is to evaluate the response of a single-parameter index (the Analgesia Nociception Index [ANI]) and a multi-parameter index (the Nociception Level [NoL] Index) when patients under combined general anaesthesia/epidural anaesthesia for laparotomies are subjected to a standardized painful stimulus (a tetanic stimulation over the ulnar nerve at 70 mA, 100 Hz for 30 seconds) at different doses of remifentanil infusion at steady state (0,005 mcg/kg/min; 0,05 mcg/kg/min; 0,1 mcg/kg/min; 0,15 mcg/kg/min). With the painful stimulus held constant but the analgesia provided gradually increased, it is expected to characterize the response of these two indices to different levels of nociception/anti-nociception balance.


Condition or disease Intervention/treatment
Pain Other: Tetanic stimulation

Detailed Description:
Patients scheduled for elective abdominal surgery by laparotomy (general surgery or gynaecological surgery) will receive a thoracic epidural (around T9-T10/T10-T11) and general anesthesia. Apart from standard monitoring, the ANI (derived from the EKG) and the NoL index (obtained via a finger probe) will be recorded. The epidural catheter will be injected with 6-10 ml of lidocaine 2% with epinephrine 5 mcg/ml to produce anesthetic level of neuraxial blocade and then be perfused with the same solution at 4-8 ml/hour. After incision and confirmation of adequate blocade with the epidural local anesthetic, the patient will receive a series of painful electric stimulation with a standard nerve stimulator applied over the ulnar nerve in tetanic mode for 30 seconds at 100 Hz and 70mA. Each stimulation will occur at a different rate of infusion of IV remifentanil at steady state (0,005 mcg/kg/min; 0,05 mcg/kg/min; 0,1 mcg/kg/min; 0,15 mcg/kg/min). A stimulation at 0,005 mcg/kg/min will be done before and after epidural loading with local anesthetics to look for altered variations in analysed parameters. The variation and the kinetic of the variations after stimulations will be observed for heart rate, mean blood pressure, BIS, ANI and NoL index.

Layout table for study information
Study Type : Observational
Actual Enrollment : 40 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Evaluation of NoL Index and ANI Variations After Nociceptive Stimulation Under Different Rates of Infusion of Intravenous Remifentanil in Patients Undergoing Laparotomies With Intraoperative Epidural Analgesia
Study Start Date : February 2015
Actual Primary Completion Date : July 2015
Actual Study Completion Date : July 2015

Group/Cohort Intervention/treatment
Tetanic stimulation
Single arm study. See Study description for a through description of the intervention.
Other: Tetanic stimulation
Standard Tetanic stimulation will be used as the stimulus to evaluate responses of the intraoperative pain indexes (ANI and NoL) at different concentration of i.v. remifentanil during anesthesia.




Primary Outcome Measures :
  1. Correlation between NoL index responses to electrical stimulus and the i.v. doses of remifentanil infusion given during anesthesia. The n of patients (40 in this study) is calculated on this primary outcome. [ Time Frame: At time of surgery ]
    The electrical stimulus will be applied on the forearm of the asleep patient at different doses of iv remifentanil (0.005mcg/kg/min to a maximum of 0.15 mcg/kg.min during anesthesia for abdominal surgery with active intraoperative epidural pain management). It will be evaluated whether or not exists a correlation between the doses of iv remifentanil and the responses of the Nol index after electrical stimulus.


Secondary Outcome Measures :
  1. NoL index changes after a standardized electrical stimulus at 4 different concentrations of iv remifentanil infusion [ Time Frame: At time of surgery ]
    Measure the NoL changes after a nociceptive stimulus at various intravenous remifentanil infusion doses.

  2. ANI index changes after a standardized electrical stimulus at 4 different concentrations of iv remifentanil infusion [ Time Frame: At time of surgery ]
    Measure the ANI changes after a nociceptive stimulus at various intravenous remifentanil infusion doses. ANI being another uniparametric pain index.

  3. Heart rate changes after a standardized electrical stimulus at 4 different concentrations of iv remifentanil infusion [ Time Frame: At time of surgery ]
    Measure the changes of Heart Rate after a nociceptive stimulus at various intravenous remifentanil infusion doses.

  4. Mean Blood Pressure changes after a standardized electrical stimulus at 4 different concentrations of iv remifentanil infusion [ Time Frame: At time of surgery ]
    Measure the changes of Heart Rate after a nociceptive stimulus at various intravenous remifentanil infusion doses.

  5. Sensitivity and specificity of NoL index, ANI index, Heart Rate and Mean blood Pressure in detecting a painful stimulus such as intubation as well as standardized electrical stimulus at remifentanil infusion of 0.005 msg/kg/min [ Time Frame: At time of surgery ]
    Measure the sensitivity and specificity of these 4 criteria in detecting a painful stimulus such as intubation and standardized electrical stimulus



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients scheduled for elective abdominal surgery by laparotomy (general surgery or gynaecological surgery) who will receive a thoracic epidural (around T9-T10/T10-T11) and general anesthesia.
Criteria

Inclusion Criteria:

  • ASA status I, II or III
  • Elective abdominal surgery with median laparotomy under general anaesthesia and epidural analgesia.

Exclusion Criteria:

  • Coronary artery disease
  • Serious cardiac arrhythmias (including atrial fibrillation)
  • Patient refusal
  • History of substance abuse
  • Chronic use of psychotropic and/or opioid drugs
  • Use of drugs that act on the autonomic nervous system (including β-blockers)
  • History of psychiatric diseases or psychological problems
  • Contraindications to epidural analgesia
  • Allergy to remifentanil
  • Unexpected difficult airway requesting excessive, possibly painful airway manipulations.
  • Dural puncture during epidural catheter installation
  • Failure of epidural analgesia
  • Surgical unexpected complications requiring strong haemodynamic support (transfusions, vasopressors, inotropes)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02602379


Locations
Layout table for location information
Canada, Quebec
Hôpital Maisonneuve-Rosemont
Montreal, Quebec, Canada
Sponsors and Collaborators
Maisonneuve-Rosemont Hospital
Medasense Biometrics Ltd
Investigators
Layout table for investigator information
Principal Investigator: Philippe Richebé, M.D. PhD Maisonneuve-Rosemont Hospital
Layout table for additonal information
Responsible Party: Philippe Richebé, MD, PhD, Professor of anesthesiology, Maisonneuve-Rosemont Hospital
ClinicalTrials.gov Identifier: NCT02602379    
Other Study ID Numbers: HMR14090
First Posted: November 11, 2015    Key Record Dates
Last Update Posted: November 18, 2016
Last Verified: November 2016
Keywords provided by Philippe Richebé, Maisonneuve-Rosemont Hospital:
Pain
Monitoring
Analgesia Nociception Index
NoL
Nociception Level
Remifentanil